abstract |
The present invention relates to 5, 6, or 7-substituted-3-(hetero)arylisoquinolamine derivatives represented by general formula D, their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by 5 administering the compounds are also included. Formula (I). R, |